Facilities and Capabilities

Berlin Chemie operates from a state-of-the-art facility in Berlin, spanning over 155,000 square meters, meticulously designed to comply with cGMP and AIFA regulations. Our facility is equipped to handle API production ranging from a few grams to several metric tons, accommodating even the most complex syntheses.

Infrastructure Highlights:

• Multi-product and Multi-purpose Lines: Our versatile manufacturing capabilities are supported by five independent production buildings and over 50 production lines.
• Total Reactor Capacity: We have a substantial reactor volume totaling 560 m^3, complemented by auxiliary equipment of 200 m^3.
• Annual Production Capacity: We produce more than 2,500 metric tons of intermediates and finished products annually.
• Advanced Technologies: The facility incorporates flow chemistry technology and high-pressure hydrogenators (up to 60 bar) to enhance our production capabilities.

Quality and Innovation

At Berlin Chemie, customer satisfaction, sustainable growth, and continuous improvement form the cornerstone of our operations. The production of Active Pharmaceutical Ingredients (APIs) involves complex problem-solving across various scientific disciplines, including Organic Chemistry, Inorganic Chemistry, Physical and Analytical Chemistry, and Environmental Management. Our success in production campaigns is a direct result of our highly skilled staff and ongoing training initiatives.

Flexibility and Efficiency

One of our key strengths is the ability to scale up processes seamlessly from the laboratory to the industrial plant while maintaining stringent standards of quality, safety, and efficiency. Our facility’s design for multi-product and multi-purpose manufacturing lines allows for exceptional flexibility, enabling rapid switches from one production process to another without compromising on quality.

Operational Excellence Analogy

To illustrate the complexity and precision of our work at Berlin Chemie, consider the preparation of a Formula 1 race car. Just as a racing car requires meticulous setup for optimal performance, starting a production campaign at our facility involves rigorous preparation—from the chemical processes developed and optimized by our Research and Technology Teams to safety analyses and final adjustments to manufacturing lines. Once initiated, the production campaign proceeds to deliver APIs that meet the exact specifications of our customers.

People-Centric Approach

At Berlin Chemie, our approach to API production places significant emphasis on human factors. We prioritize the well-being of both our customers and our employees, fostering an environment where each individual can thrive and contribute to our shared goals.

Conclusion

Berlin Chemie is more than just a pharmaceutical company; it is a hub of innovation, quality, and efficiency. Our advanced facilities, combined with a profound commitment to our clients and staff, ensure that we remain leaders in the pharmaceutical manufacturing industry, dedicated to improving health outcomes worldwide.